Search
01/01/2025
Introduction of the 10th World Symposium for Lymphedema Surgery
Cheng, MH, Chang, DW, Masia, J. Introduction of the 10th World Symposium for Lymphedema Surgery. JOURNAL OF SURGICAL ONCOLOGY. 2025; 131(1)DOI:10.1002/jso.27919. PMID:39387585. IF:1.900(Q2/4D).
01/01/2025
Reply to Letter Re: Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery
Fa-Binefa, M, Rojas-Sayol, R. Reply to Letter Re: Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery. JOURNAL OF ARTHROPLASTY. 2025; 40(1)DOI:10.1016/j.arth.2024.09.036. PMID:39615984. IF:3.800(Q1/2D).
01/01/2025
Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis
Olivé-Cirera, G, Fonseca, E, Chen, LW, Fetta, A, Martínez-Hernández, E, Guasp, M, González-Alvarez, V, Delgadillo, V, Cantarín-Extremera, V, Jiménez-Legido, M, Monge-Galindo, L, Felipe, A, Beseler, B, Turón-Viñas, E, Fernández-Ramos, J, Martínez-González, MJ, Vázquez-López, M, Fernandez, LA, Alvarez-Molinero, M, Muñoz-Cabello, B, Camacho, A, Nuñez-Enamorado, N, Spatola, M, Sabater, L, Blanco, Y, Saiz, A, Graus, F, Dalmau, J, Armangué, T. Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis. LANCET NEUROLOGY. 2025; 24(1)DOI:10.1016/S1474-4422(24)00443-5. PMID:39706634. IF:45.500(Q1/1D).
01/01/2025
Late gadolinium enhancement and outcome of cardiac resynchronization therapy in non-ischemic cardiomyopathy
Anguera, I, Faga, V, Jimenez-Candil, J, Moreno-Weidmann, Z, Santos-Ortega, A, Jimenez-Jaimez, J, Rodriguez-García, J, Claver, E, Meré, J, Jovells-Vaque, S, Diez-Lopez, C, Hernández, J, Rivas-Gandara, N, Macías, R, García-Cosculluela, D, Comin-Colet, J, Di Marco, A. Late gadolinium enhancement and outcome of cardiac resynchronization therapy in non-ischemic cardiomyopathy. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2025; 418DOI:10.1016/j.ijcard.2024.132618. PMID:39384095. IF:3.200(Q2/3D).
01/01/2025
Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR
Avvedimento, M, Cepas-Guillén, P, Ternacle, J, Urena, M, Alperi, A, Cheema, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, del Trigo, M, Muñoz-Garcia, A, Maneiro, N, Asmarats, L, Regueiro, A, del Val, D, Serra, V, Auffret, V, Modine, T, Bonnet, G, Mesnier, J, Suc, G, Avanzas, P, Rezaei, E, Fradejas-Sastre, V, Tirado-Conte, G, Fernández-Nofrerias, E, Franzone, A, Guitteny, T, Sorrentino, S, Oteo, JF, Nuche, J, Gutiérrez-Alonso, L, Flores-Umanzor, E, Alfonso, F, Monastyrski, A, Nolf, M, Côté, M, Mehran, R, Morice, MC, Capodanno, D, Garot, P, Rodés-Cabau, J. Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR. Circulation-Cardiovascular Interventions. 2025; 18(1)DOI:10.1161/CIRCINTERVENTIONS.124.014800. PMID:39475194. IF:7.400(Q1/2D).
01/01/2025
Lipid-lowering therapy after acute coronary syndromes: a multinational European survey
Tsaban, G, Perez, RV, Krychtiuk, KA, Ahrens, I, Halvorsen, S, Hassager, C, Huber, K, Schiele, F, Sionis, A, Claeys, MJ. Lipid-lowering therapy after acute coronary syndromes: a multinational European survey. CORONARY ARTERY DISEASE. 2025; 36(1)DOI:10.1097/MCA.0000000000001420. PMID:39263716. IF:2.000(Q3/6D).
01/01/2025
Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study
Hidalgo, OB, Alonso, CM, Jaime, FJL, Carrasco, M, Hernández, MDN, Afonso, N, Lei, A, Whyms, D, Hanna, K, Aragonés, ME, Torres, M, Oliveras, J. Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2025; 31DOI:10.1177/10760296251327593. PMID:40079811. IF:2.000(Q3/6D).
01/01/2025
Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome
Vilalta, N, Oñate, G, Triquell, M, Carrasco, M, Mateo, J. Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).